Predictors of major adverse lower limb events in patients with tissue loss secondary to critical limb-threatening ischemia

医学 严重肢体缺血 血运重建 截肢 外科 比例危险模型 血管外科 缺血 回顾性队列研究 单变量分析 内科学 血管疾病 动脉疾病 多元分析 心脏外科 心肌梗塞
作者
Valérian Vosgin-Dinclaux,Paul Bertucat,Loubna Dari,Claire Webster,Ninon Foussard,Kamel Mohammedi,Éric Ducasse,Caroline Caradu
出处
期刊:Cardiovascular Revascularization Medicine [Elsevier BV]
被引量:2
标识
DOI:10.1016/j.carrev.2024.01.018
摘要

Chronic limb-threatening ischemia (CLTI) is the end-stage of peripheral arterial disease (PAD) posing a high risk for limb loss and mortality. This study aims to evaluate and list possible predictors of major adverse limb events (MALEs) in CLTI patients with tissue loss.This retrospective study included all Rutherford-Becker stage 5 or 6 patients who required foot debridement and revascularization in our department from January 2016 to December 2018. The limbs were classified according to the TASC II, GLASS and WiFI grading systems. The primary composite outcome was MALEs at 2 years. The secondary outcomes included all-cause mortality, primary patency, freedom from reintervention, and major amputation. Kaplan-Meier estimates were used to determine the event rates, and Cox proportional hazards model with the index MALE as a time-dependent covariate was used to search for MALEs predictors.Of 241 included patients, 19 underwent open surgeries (7.9 %) 207 had endovascular interventions (85.9 %) and 15 required a hybrid approach (6.2 %). On univariate analysis, patients who experienced MALEs (n = 111) more often required hemodialysis (25 vs 15; p = .02), presented with more complex lesions (TASC D on femoropopliteal (p = .05) or below the knee (BTK) arteries (p = .006) with increasing infra-inguinal GLASS Stage (p < .0001)), a history of index limb open (p = .009) or endovascular (p = .049) revascularization, an occluded tibial artery (p = .002 for the posterior tibial and p = .052 for the anterior tibial), or a "desert foot" (p = .02). The CRP level was also higher at admission (p = .001). Technical success of BTK revascularization significantly reduced MALEs (p < .0001) along with the number of patent BTK vessels (p = .0007). Independent predictors of MALEs included hemodialysis (HR = 2.00; 95%CI: 1.14 to 3.39), pulsatile arterial pressure (HR = 1.01; 95%CI: 1.00 to 1.03) and the infra-inguinal GLASS Stage (HR = 2.50; 95%CI: 1.17 to 5.82). We could not correlate our results with the WiFI scores for amputation risk and revascularization benefit.For patients with CLTI at the stage of trophic disorders, with or without a history of index limb revascularization, the GLASS successfully predicted MALEs. Hemodialysis and high pulsatile arterial pressure increased the risk of MALEs. The WiFI score did not demonstrate its interest in this subgroup of patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
AYJ完成签到,获得积分10
2秒前
YY完成签到,获得积分10
2秒前
888发布了新的文献求助50
3秒前
顾矜应助芝士滑蛋牛肉堡采纳,获得10
4秒前
5秒前
5秒前
5秒前
杨旸完成签到,获得积分10
5秒前
6秒前
舞雩完成签到 ,获得积分10
6秒前
6秒前
Oasis完成签到,获得积分10
7秒前
今后应助爽大包采纳,获得10
8秒前
ykh发布了新的文献求助10
10秒前
10秒前
10秒前
青松发布了新的文献求助10
11秒前
wjx发布了新的文献求助10
11秒前
所所应助347采纳,获得10
12秒前
科研通AI6.1应助1762571452采纳,获得10
13秒前
14秒前
Akim应助啦啦啦采纳,获得10
14秒前
王美祥发布了新的文献求助10
14秒前
小奇葩发布了新的文献求助10
15秒前
小二郎应助雁回采纳,获得10
15秒前
16秒前
17秒前
17秒前
18秒前
20秒前
Liaoluqing发布了新的文献求助10
21秒前
22秒前
爆米花应助ykh采纳,获得10
23秒前
寒小晗发布了新的文献求助10
23秒前
希望天下0贩的0应助cqwswfl采纳,获得10
24秒前
alopiidae完成签到,获得积分10
24秒前
CodeCraft应助yuan66781采纳,获得30
24秒前
称心的代珊完成签到,获得积分10
24秒前
25秒前
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Quality by Design - An Indispensable Approach to Accelerate Biopharmaceutical Product Development 800
Pulse width control of a 3-phase inverter with non sinusoidal phase voltages 777
Signals, Systems, and Signal Processing 610
Research Methods for Applied Linguistics: A Practical Guide 600
Research Methods for Applied Linguistics 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6403039
求助须知:如何正确求助?哪些是违规求助? 8221181
关于积分的说明 17424132
捐赠科研通 5455645
什么是DOI,文献DOI怎么找? 2883202
邀请新用户注册赠送积分活动 1859451
关于科研通互助平台的介绍 1700935